This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2021.
Company Filing History:
1 out of 181 
1 out of 911 
Years Active: 2021
Title: **Vladimir Yutkin: Innovator in Urogenital Cancer Treatment**
Introduction
Vladimir Yutkin, an accomplished inventor based in Rehovot, Israel, has made significant contributions to medical science, particularly in the field of cancer treatment. With a focus on utilizing pathogenic bacteria as a therapeutic agent, he has developed innovative solutions aimed at combating urogenital cancers.
Latest Patents
Yutkin holds a patent for "Attenuated or inactivated pathogenic bacteria for treating urogenital cancer." This groundbreaking invention presents a method that involves using modified bacteria with anti-cancer properties. It provides compositions comprising these bacteria and discusses various applications for treating cancers of the urogenital system, showcasing his forward-thinking approach to cancer therapy.
Career Highlights
Throughout his career, Vladimir has worked with esteemed organizations that contribute to medical research and development. He has been affiliated with the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., where he has engaged in innovative projects that bridge academic research and practical applications. Additionally, he has contributed his expertise to Hadasit Medical Research Services and Development Ltd., further solidifying his reputation within the research community.
Collaborations
Vladimir Yutkin has collaborated with notable colleagues in the scientific field, including Ofer Mandelboim and Gilad Benjamin Bachrach. These partnerships have enriched his work and expanded the impact of his research, fostering a collaborative environment aimed at enhancing cancer treatment methodologies.
Conclusion
With a patent that underscores the potential of using modified pathogenic bacteria in treating urogenital cancer, Vladimir Yutkin exemplifies the spirit of innovation in the medical field. His dedication to research and collaboration positions him as a key figure in advancing therapeutic options for patients suffering from cancer. Through his work, Yutkin continues to inspire future innovations in cancer treatment and beyond.